China · Delayed Price · Currency is CNY Youngy Health Statistics
Total Valuation
Youngy Health has a market cap or net worth of CNY 3.05 billion. The enterprise value is 2.70 billion.
| Market Cap | 3.05B |
| Enterprise Value | 2.70B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Youngy Health has 804.04 million shares outstanding. The number of shares has increased by 6.36% in one year.
| Current Share Class | 804.04M |
| Shares Outstanding | 804.04M |
| Shares Change (YoY) | +6.36% |
| Shares Change (QoQ) | -0.17% |
| Owned by Insiders (%) | 1.60% |
| Owned by Institutions (%) | 1.37% |
| Float | 674.23M |
Valuation Ratios
The trailing PE ratio is 44.05.
| PE Ratio | 44.05 |
| Forward PE | n/a |
| PS Ratio | 3.40 |
| PB Ratio | 2.34 |
| P/TBV Ratio | 2.68 |
| P/FCF Ratio | 57.63 |
| P/OCF Ratio | 44.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.59, with an EV/FCF ratio of 51.06.
| EV / Earnings | 37.77 |
| EV / Sales | 3.01 |
| EV / EBITDA | 15.59 |
| EV / EBIT | 18.09 |
| EV / FCF | 51.06 |
Financial Position
The company has a current ratio of 7.11, with a Debt / Equity ratio of 0.06.
| Current Ratio | 7.11 |
| Quick Ratio | 3.70 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.43 |
| Debt / FCF | 1.39 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.66% and return on invested capital (ROIC) is 12.62%.
| Return on Equity (ROE) | 8.66% |
| Return on Assets (ROA) | 6.20% |
| Return on Invested Capital (ROIC) | 12.62% |
| Return on Capital Employed (ROCE) | 10.73% |
| Weighted Average Cost of Capital (WACC) | 5.67% |
| Revenue Per Employee | 1.57M |
| Profits Per Employee | 125,647 |
| Employee Count | 569 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 2.24 |
Taxes
In the past 12 months, Youngy Health has paid 54.23 million in taxes.
| Income Tax | 54.23M |
| Effective Tax Rate | 33.34% |
Stock Price Statistics
The stock price has decreased by -14.57% in the last 52 weeks. The beta is 0.28, so Youngy Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -14.57% |
| 50-Day Moving Average | 3.74 |
| 200-Day Moving Average | 4.52 |
| Relative Strength Index (RSI) | 56.67 |
| Average Volume (20 Days) | 15,322,277 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Youngy Health had revenue of CNY 895.79 million and earned 71.49 million in profits. Earnings per share was 0.09.
| Revenue | 895.79M |
| Gross Profit | 356.76M |
| Operating Income | 149.22M |
| Pretax Income | 162.68M |
| Net Income | 71.49M |
| EBITDA | 165.38M |
| EBIT | 149.22M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 545.74 million in cash and 73.69 million in debt, with a net cash position of 472.05 million or 0.59 per share.
| Cash & Cash Equivalents | 545.74M |
| Total Debt | 73.69M |
| Net Cash | 472.05M |
| Net Cash Per Share | 0.59 |
| Equity (Book Value) | 1.30B |
| Book Value Per Share | 1.46 |
| Working Capital | 974.79M |
Cash Flow
In the last 12 months, operating cash flow was 68.01 million and capital expenditures -15.13 million, giving a free cash flow of 52.88 million.
| Operating Cash Flow | 68.01M |
| Capital Expenditures | -15.13M |
| Depreciation & Amortization | 16.16M |
| Net Borrowing | -11.13M |
| Free Cash Flow | 52.88M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 39.83%, with operating and profit margins of 16.66% and 7.98%.
| Gross Margin | 39.83% |
| Operating Margin | 16.66% |
| Pretax Margin | 18.16% |
| Profit Margin | 7.98% |
| EBITDA Margin | 18.46% |
| EBIT Margin | 16.66% |
| FCF Margin | 5.90% |
Dividends & Yields
Youngy Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.36% |
| Shareholder Yield | -6.36% |
| Earnings Yield | 2.35% |
| FCF Yield | 1.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 29, 2016. It was a forward split with a ratio of 2.
| Last Split Date | Apr 29, 2016 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |